Mass. Gene Therapy Co. Nabs $110M Series C Financing
Generation Bio, a Cambridge, Massachusetts-based gene therapy company, announced Friday the closing of a $110 million Series C financing it says will be used to advance liver-targeted programs for hemophilia A...To view the full article, register now.
Already a subscriber? Click here to view full article